B. Braun Receives FDA Approval For Next Generation 1L Intravenous Containers E3™ -The latest advancement in IV container technology in more than 25 years
BETHLEHEM, Pa., Jan. 31, 2014 /PRNewswire/ -- B. Braun Medical Inc. (B.Braun), a leader in infusion therapy and pain management, announced today that it has received FDA approval of 5% Dextrose and 0.45% Sodium Chloride Injection USP in 1L IV containers. B.Braun's E3™ IV containers are a first of its kind offering that will provide healthcare professionals with the highest quality, easy to use IV containers that are not made with natural rubber latex, DEHP or PVC.
"B.Braun's commitment to increasing capacity to meet market demands has never been stronger, as evidenced by our investment in the next generation of IV container offerings," said Rick Williamson, Vice President of Pharmaceutical Marketing at B.Braun. "The approval moves B.Braun towards its goal to increase capacity by 15% over the next 12 months," added Williamson.
B.Braun continues to lead the way in offering the only full line of IV solution products that are manufactured using non-toxic plastic materials – a true testament to B.Braun's ecological awareness and patient-centric philosophy. With the addition of the new E3 IV containers, B.Braun will expand its line of solution containers that are not made with natural rubber latex, DEHP or PVC. Exposure to these toxic materials has been a growing concern for healthcare facilities around the world. Studies show that excessive exposure to DEHP can potentially lead to adverse health effects, especially to a patient's liver, kidneys and lungs, as well as their heart rate and blood pressure. More than three decades ago, B.Braun recognized the environmental and patient risks posed by products containing DEHP and PVC. As a result, B.Braun was the first medical device manufacturer to remove these harmful substances from many products and today is the only supplier that offers a full line of solution containers that are not made with DEHP or PVC. B.Braun is keenly focused on continuing to find alternative methods to manufacture safer products such as the E3 IV containers.
E3™ IV containers are manufactured biologically inert, using non-toxic plastic materials. The innovative, blow-filled technology used during manufacturing provides a seamless container design for safe, rapid and accurate fluid delivery. The sturdy port system allows for easier set access and medication additions. The lack of over wrap makes E3 environmentally friendly and easy to store at room temperature.
Customers interested in more information please call 1-800-227-2862.
About B. Braun
B. Braun Medical Inc. (B.Braun), a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry. The Company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. Guided by its "Sharing Expertise®" philosophy, B.Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs.
The B.Braun Group of Companies in the U.S. includes B.Braun, B.Braun Interventional Systems, Aesculap® and CAPS®. B.Braun's U.S. headquarters is located in Bethlehem, Pennsylvania. The B.Braun Group of Companies employs more than 46,000 employees in more than 50 countries throughout the world. To learn more about B.Braun visit www.BBraunUSA.com.
SOURCE B. Braun Medical Inc.